• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LYU Hongyan.The progress of concomitant administration of haloperidol with other drugs in the treatment of tic disorders and schizophrenia in children[J].Journal Of Pharmaceutical Research,2022,41(6):410-413,420[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2641times   Download 2229次 QR Code for this article
Scan with your phone!
氟哌啶醇联合用药治疗儿童抽动障碍及精神分裂症的研究进展
吕红艳
Font:Larger+|Default|Smaller-
(济宁市第一人民医院儿科,山东 济宁 272000)
摘要:
氟哌啶醇为一种重要的抗精神分裂药,临床上用于治疗精神疾病引起的行为冲动和焦虑等症状,但单独使用该药物治疗的总有效率较低,与其他类型药物联合用于精神疾病的治疗往往具有更好的疗效和安全性。本文就近年来关于氟哌啶醇联合用药治疗儿童抽动障碍及精神分裂症的情况进行综述,探讨氟哌啶醇联合用药用于儿童抽动障碍及精神分裂症方面的研究进展,为临床用药提供参考依据。
关键词:  氟哌啶醇  抽动障碍  精神分裂症  联合用药
DOI:10.13506/j.cnki.jpr.2022.06.013
基金项目:
The progress of concomitant administration of haloperidol with other drugs in the treatment of tic disorders and schizophrenia in children
LYU Hongyan
(Department of Pediatrics, Jining No.1 People's Hospital,Jining 272000,China)
Abstract:
Haloperidol is a typical antipsychotic drug used to treat the symptoms of behavioral impulse and anxiety caused by mental diseases. However, the total effective rate of using haloperidol alone is low. The concomitant administration of haloperidol with other drugs often has better efficacy and safety to treat mental diseases. The paper reviewed the important progress and discussed the the advantages of haloperidol concomitant administration in the treatment of tic disorder and schizophrenia in children, so as to provide basis for clinical medication.
Key words:  Haloperidol  Tic disorders  Schizophrenia  Combination
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.